Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24

Background Phagocytic clearance by macrophages represents a critical immune surveillance mechanism in cancer liver metastasis. Neutrophils, the most abundant immune cells encountered by cancer cells in circulation, play key roles in metastasis through neutrophil extracellular traps (NETs). Although...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Liu, Xiaoli Zhang, Kun Chen, Hongying Wang, Junhu Yuan, Yiming Ma, Jianhui Ma, Fanyu Zhang, Bing-zhi Wang, Yinong Wang, Xinhua Zhao
Format: Article
Language:English
Published: BMJ Publishing Group 2025-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/2/e010813.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850057934843674624
author Yu Liu
Xiaoli Zhang
Kun Chen
Hongying Wang
Junhu Yuan
Yiming Ma
Jianhui Ma
Fanyu Zhang
Bing-zhi Wang
Yinong Wang
Xinhua Zhao
author_facet Yu Liu
Xiaoli Zhang
Kun Chen
Hongying Wang
Junhu Yuan
Yiming Ma
Jianhui Ma
Fanyu Zhang
Bing-zhi Wang
Yinong Wang
Xinhua Zhao
author_sort Yu Liu
collection DOAJ
description Background Phagocytic clearance by macrophages represents a critical immune surveillance mechanism in cancer liver metastasis. Neutrophils, the most abundant immune cells encountered by cancer cells in circulation, play key roles in metastasis through neutrophil extracellular traps (NETs). Although NETs promote macrophage phagocytosis during infection, whether they regulate phagocytosis during cancer metastasis is unknown. The present study aimed to explore the roles of NETs in regulating macrophage phagocytosis during the seeding process of liver metastasis and the mechanisms underlying the roles.Methods A lipopolysaccharide-induced NET model was applied to study the role of NETs on colorectal cancer (CRC) liver metastasis. The neutrophils isolated from human peripheral blood were stimulated with PMA to release NETs, which were collected and added to the cultures of different CRC cell lines for in vitro studies. Macrophage phagocytosis was assessed with flow cytometry in vitro and in vivo. RNA-seq and microRNA array analyses were performed to identify key pathways regulated by NETs and downstream key molecules. The macrophage phenotypes were evaluated using immunohistochemistry, flow cytometry, and cytokine and chemokine arrays.Results NETs promote macrophage phagocytosis both in vitro and in vivo. Neutrophil elastase (NE), which was able to inactivate the canonical signal of protease-activated receptor 2 (PAR2), downregulated the phagocytotic checkpoint CD24. Notably, PAR2 deficiency imitated the effect of NETs on phagocytosis and CD24. Mechanistic studies indicated that inhibiting PAR2 expression upregulated miR-34a and miR-146a and downregulated CD24 in cancer cells. In addition, PAR2 depletion enhanced the recruitment and M1 polarization of macrophages by upregulating CSF-1 and CXCL1. The correlation of NETs/NE and CD24 was corroborated using human CRC specimens. Furthermore, PAR2 blockade combined with an anti-EGFR antibody (cetuximab (CTX)) synergistically enhanced the phagocytic ability of macrophages and suppressed liver metastasis in vivo.Conclusions NET-derived elastase inactivated PAR2 canonical signaling and promoted phagocytosis by downregulating CD24, which functions as a phagocytotic checkpoint in CRC liver metastasis. Thus, PAR2 inhibitors combined with CTX may serve as a novel therapeutic strategy against advanced CRC.
format Article
id doaj-art-2ecb82ce7f164e3d9be2be9e9dd53ad9
institution DOAJ
issn 2051-1426
language English
publishDate 2025-02-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-2ecb82ce7f164e3d9be2be9e9dd53ad92025-08-20T02:51:18ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-02-0113210.1136/jitc-2024-010813Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24Yu Liu0Xiaoli Zhang1Kun Chen2Hongying Wang3Junhu Yuan4Yiming Ma5Jianhui Ma6Fanyu Zhang7Bing-zhi Wang8Yinong Wang9Xinhua Zhao101 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China5 Department of Injury and Repair, Beijing Neurosurgical Institute, Capital Medical University, Beijing, Beijing, China3 Department of Immunology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Liaoning, China1 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China1 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China1 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China1 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China1 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China2 Department of Pathology and Resident Training Base, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China1 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China1 State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, ChinaBackground Phagocytic clearance by macrophages represents a critical immune surveillance mechanism in cancer liver metastasis. Neutrophils, the most abundant immune cells encountered by cancer cells in circulation, play key roles in metastasis through neutrophil extracellular traps (NETs). Although NETs promote macrophage phagocytosis during infection, whether they regulate phagocytosis during cancer metastasis is unknown. The present study aimed to explore the roles of NETs in regulating macrophage phagocytosis during the seeding process of liver metastasis and the mechanisms underlying the roles.Methods A lipopolysaccharide-induced NET model was applied to study the role of NETs on colorectal cancer (CRC) liver metastasis. The neutrophils isolated from human peripheral blood were stimulated with PMA to release NETs, which were collected and added to the cultures of different CRC cell lines for in vitro studies. Macrophage phagocytosis was assessed with flow cytometry in vitro and in vivo. RNA-seq and microRNA array analyses were performed to identify key pathways regulated by NETs and downstream key molecules. The macrophage phenotypes were evaluated using immunohistochemistry, flow cytometry, and cytokine and chemokine arrays.Results NETs promote macrophage phagocytosis both in vitro and in vivo. Neutrophil elastase (NE), which was able to inactivate the canonical signal of protease-activated receptor 2 (PAR2), downregulated the phagocytotic checkpoint CD24. Notably, PAR2 deficiency imitated the effect of NETs on phagocytosis and CD24. Mechanistic studies indicated that inhibiting PAR2 expression upregulated miR-34a and miR-146a and downregulated CD24 in cancer cells. In addition, PAR2 depletion enhanced the recruitment and M1 polarization of macrophages by upregulating CSF-1 and CXCL1. The correlation of NETs/NE and CD24 was corroborated using human CRC specimens. Furthermore, PAR2 blockade combined with an anti-EGFR antibody (cetuximab (CTX)) synergistically enhanced the phagocytic ability of macrophages and suppressed liver metastasis in vivo.Conclusions NET-derived elastase inactivated PAR2 canonical signaling and promoted phagocytosis by downregulating CD24, which functions as a phagocytotic checkpoint in CRC liver metastasis. Thus, PAR2 inhibitors combined with CTX may serve as a novel therapeutic strategy against advanced CRC.https://jitc.bmj.com/content/13/2/e010813.full
spellingShingle Yu Liu
Xiaoli Zhang
Kun Chen
Hongying Wang
Junhu Yuan
Yiming Ma
Jianhui Ma
Fanyu Zhang
Bing-zhi Wang
Yinong Wang
Xinhua Zhao
Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24
Journal for ImmunoTherapy of Cancer
title Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24
title_full Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24
title_fullStr Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24
title_full_unstemmed Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24
title_short Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24
title_sort neutrophil extracellular traps impede cancer metastatic seeding via protease activated receptor 2 mediated downregulation of phagocytic checkpoint cd24
url https://jitc.bmj.com/content/13/2/e010813.full
work_keys_str_mv AT yuliu neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT xiaolizhang neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT kunchen neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT hongyingwang neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT junhuyuan neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT yimingma neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT jianhuima neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT fanyuzhang neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT bingzhiwang neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT yinongwang neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24
AT xinhuazhao neutrophilextracellulartrapsimpedecancermetastaticseedingviaproteaseactivatedreceptor2mediateddownregulationofphagocyticcheckpointcd24